FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093668 [Registered on: 26/08/2025] Trial Registered Prospectively
Last Modified On: 25/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Studying Choline Levels in Cancer Patients of Gall-Bladder Upon Using Radiological Imaging Modalities (MR Spectroscopy) 
Scientific Title of Study   Evaluation of choline levels in gall bladder carcinoma using magnetic resonance spectroscopy. 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anjali Kumari  
Designation  Junior Resident 
Affiliation  Jawaharlal Nehru Medical College(Datta meghe institute of higher education and research) 
Address  Department of Radio-diagnosis, Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha, Maharashtra-442001

Wardha
MAHARASHTRA
442001
India 
Phone  8550988657  
Fax    
Email  anjalikr7878@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Gaurav V Mishra  
Designation  Associate Professor 
Affiliation  Jawaharlal Nehru Medical College(Datta meghe institute of higher education and research) 
Address  Department of Radio-diagnosis, Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha, Maharashtra-442001

Wardha
MAHARASHTRA
442001
India 
Phone  9109053055  
Fax    
Email  gaurav.mishra@dmiher.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Gaurav V Mishra  
Designation  Associate Professor 
Affiliation  Jawaharlal Nehru Medical College(Datta meghe institute of higher education and research) 
Address  Department of Radio-diagnosis, Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha, Maharashtra-442001

Wardha
MAHARASHTRA
442001
India 
Phone  9109053055  
Fax    
Email  gaurav.mishra@dmiher.edu.in  
 
Source of Monetary or Material Support  
Datta Meghe Institute Of higher education and research,Sawangi,Wardha,India ,442001 
 
Primary Sponsor  
Name  Jawaharlal Nehru Medical College Datta Meghe Institute Of higher education and research 
Address  Department Of Radio-Diagnosis, Jawaharlal Nehru Medical College, Sawangi, Wardha, 442001 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anjali Kumari   Datta Meghe Institute Of Higher Education and Research  MRI Imaging Room,Division of MRI Imaging, Department Of Radio-Diagnosis Acharya Vinoba Bhave Rural Hospital Sawangi
Wardha
MAHARASHTRA 
8550988657

anjalikr7878@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Datta Meghe Institute of Higher Education and Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C23||Malignant neoplasm of gallbladder,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Radiological Voxel on MRI  A voxel is a measurement of volume in a structure that is to be imaged. Each voxel represents a defined volume, and can be localized by coordinates on a three-dimensional grid. Both CT and MRI scanners image a slab of tissue and describe it in a two-dimensional image on the computer screen. Each image is made up of a matrix of two-dimensional cells called pixels. Each pixel represents a volume of tissue, or voxel. The voxel has the same 2-D (x-axis, y-axis) size as the pixel, but the third dimension (z-axis) is equivalent to the slice thickness of the scan. To Evaluate Choline Levels in Carcinoma Gall Bladder a Radiological Voxel is placed at the site of Carcinoma before performing MR Spectroscopy. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1)To study the spectrum of MRI findings in gall bladder carcinoma.
2)To determine the choline levels under MR Spectroscopy in gall bladder carcinoma.
 
 
ExclusionCriteria 
Details  1. A patient who had surgery or medical care
in the past.

2. Women who are pregnant.

3. Patients with pacemakers, cochlear implants, or
metallic implants.

4. Patients with any type of psychological
condition including claustrophobia.

5. Patients who are unwilling or uncooperative.
 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
Establish the co-relation between choline levels peak and likelihood of metastasis of Ca Gallbladder at the site of Choline Peak with the help of MR Spectroscopy.  All patients will be assessed at the end of 3 months. 
 
Secondary Outcome  
Outcome  TimePoints 
To explore the potential of MR spectroscopy in detecting choline levels as a biomarker for gall bladder carcinoma.  All patients will be assessed at the end of 3 months. 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Gallbladder carcinoma is a relatively rare but highly aggressive malignancy of the biliary tract with poor prognosis mainly  due to its often late diagnosis and limited treatment options. Early detection and accurate staging of GBC are crucial for improving patient outcome. MRI have shown promise in enhancing accuracy and prognostic values in GB carcinoma patients. MRS enables the non-invasive assessment of metabolites levels within tissues offering insights into cellular metabolites and providing biomarkers for cancer detection and characterization. One such metabolite of interest is choline, a component of cell membrane whose elevation levels has been associated with increased cell proliferation and malignant transformation. Therefore this study will aim to investigate the role of MRI and MR spectroscopy in evaluating choline levels in GB carcinoma patients to improve early detection and guide personalized treatment for this aggressive malignancy. 
Close